Popular Sausage Brand Recalls 22,000 Pounds Of Bratwurst Over Hard Plastic Hazard
Wisconsin-based sausage company Johnsonville is recalling its Brats Cheddar Bratwurst due to it possibly containing hard plastic, the U.S. Department of Agriculture's Food Safety and Inspection Service (FSIS) has announced. The cheddar bratwurst product is sold in a 19-ounce package that contains five sausages. Affected packages bear the code B9FOD and the establishment number "Est. 1647," both of which are printed on the front. The compromised sausages were shipped to stores in the following states: Georgia, Indiana, Kansas, Kentucky, Michigan, Minnesota, Ohio, Tennessee, Virginia, and Wisconsin. This recall of 22,672 pounds of bratwurst comes after two customers reported finding hard plastic inside their purchased sausages.
Although nobody has yet been hurt as a result of this foreign material contamination, the FSIS recall is marked as Class I, which, just as it does on the FDA's recall classification scale, indicates that the consumption of this product could cause serious health issues and even death. As such, customers who currently own the recalled product should not consume it! The FSIS advises you to throw it away or return it to the retailer you purchased it from. For additional information, the public can contact a Johnsonville rep, Amanda Fritsch, by calling 888-556-2728 or emailing anachtweyfritsch@johnsonville.com with any additional questions.
Read more: Store-Bought Frozen Meatballs, Ranked Worst To Best
Although Johnsonville is the frozen meatball brand we'd buy again and again, the popular sausage company is, unfortunately, no stranger to recalls. In 2024, its Polish Kielbasa Turkey Sausages were recalled in another Class I recall, citing possible contamination with rubber pieces. And, about a year earlier, over 42,000 pounds of Johnsonville Beddar with Cheddar Smoked Sausage links were recalled, again over concerns that they contained plastic fibers. The year 2019 even saw two foreign material recalls by the company, one in January and the other in May.
In the first, over 48,000 pounds of pork were recalled due to possible rubber contamination, while the second recalled more than 95,000 pounds of jalapeño smoked sausage because it potentially contained hard green plastic. Both plastic and rubber (or "foreign material" as they're often referred to in these recalls) can cause choking and internal injuries and are therefore considered dangerous if consumed. The FSIS advises people who may have eaten the recalled products to speak to their healthcare provider. If, after reading this, you're wondering how U.S. food agencies work, here's a breakdown of how the FDA differs from the USDA when it comes to food regulations.
Read the original article on Tasting Table.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
an hour ago
- Business Wire
Emulate Launches AVA™ Emulation System to Accelerate Drug Development With First-of-its-Kind High-Throughput Organ-Chip Platform
BOSTON--(BUSINESS WIRE)--Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System, a self-contained instrument that cultures, incubates, and images up to 96 independent Organ-Chip samples in a single run. AVA delivers an unprecedented magnitude of in vivo -level insights faster than animal models while cutting consumable costs four-fold and in-lab labor by half compared to current generation technologies. These transformative capabilities give the pharmaceutical industry the practical means to pivot beyond animal testing and into truly human-relevant territory. With the FDA targeting animal studies to become 'the exception rather than the norm,' the need for proven human models is urgent. Emulate's Liver-Chip S1—the first and only Organ-Chip admitted to the FDA's ISTAND program. Share 'AVA gives scientists unprecedented experimental capacity with the biological depth of live human tissue—something no other platform can match,' said Jim Corbett, Chief Executive Officer at Emulate. 'By combining Emulate's proven Organ-on-a-Chip technology with high-throughput consumables, automated imaging, and streamlined workflows in one benchtop unit, AVA lets teams ask bigger questions earlier and move the right drug candidates forward faster.' AVA Emulation System: Three Instruments in One AVA is the first self-contained Organ-on-a-Chip workstation to fuse high-throughput microfluidic tissue culture, full environmental control, and real-time imaging into a single, compact benchtop unit. Key performance gains include: Expanded experimental power – 96 independent Organ-Chip samples in a single run enable researchers to achieve microplate-level scale of their Organ-Chip experiments, enabling side-by-side comparison of dozens of compounds, doses, or stimuli. Lower operating costs – AVA achieves a four-fold drop in consumable spend and up to 50% fewer cells and media per sample compared to previous generation technology. Time & labor savings – Hands-on, in-lab time is reduced by more than half, thanks to automated microscopy, remote monitoring, and the revolutionary new Chip-Array™ consumable that integrates 12 independent Organ-Chips into an SBS format for streamlined workflows with multichannel pipettes and automated liquid handlers. AI-ready datasets – A typical 7-day experiment can generate >30,000 time-stamped data points from daily imaging and effluent assays, with post-takedown omics pushing the total into the millions—providing a rich, multi-modal foundation to feed machine-learning pipelines for target discovery, lead optimization, and safety prediction. A Timely Answer to Shifting Regulations With the FDA targeting animal studies to become 'the exception rather than the norm,' the need for proven human models is urgent. Emulate's Liver-Chip S1—the first and only Organ-Chip admitted to the FDA's ISTAND program—has already outperformed animals, showing 87% sensitivity and 100% specificity for drug-induced liver injury in a 2022 Communications Medicine study. AVA now scales that level of human relevance across discovery, efficacy, and toxicology screens, accelerating safer therapies through the pipeline. 'Moving towards reduction and in some cases replacement of animal models demands both biological fidelity and throughput,' noted Dr. Lorna Ewart, Emulate Chief Scientific Officer. 'AVA meets those dual requirements, empowering teams to rank-order lead candidates, pinpoint off-target toxicities, and advance safer therapies with unprecedented speed and confidence.' Broad Impact Across Industries In biopharma, this type of reduction and replacement is already a reality. A leading pharmaceutical company has demonstrated the power of implementing Organ-Chips into their development pipeline when one of their scientists saved millions of dollars and years of development time by using Emulate Liver-Chips ahead of non-human primates to screen lipid-nanoparticle (LNP) candidates. AVA's leap in throughput of predictive human biology stands to benefit not only biopharma but a wide spectrum of sectors that currently rely on inaccurate animal testing. Large pharmaceutical pipelines can now run comparable screens in a single AVA experiment, while smaller biotech teams gain enterprise-level capacity without adding headcount or infrastructure. Beyond therapeutics, contract research organizations, consumer-product companies, and environmental agencies can harness AVA to evaluate industrial chemicals, food additives, and cosmetic ingredients under human-relevant conditions—bringing faster, more ethical safety and efficacy decisions to market-driven and regulatory programs alike. Availability Global orders are open immediately. For pricing or demonstrations, please submit a request here. About Emulate Emulate, Inc. is the pioneer of Organ-on-a-Chip technology, enabling researchers to accurately replicate human tissue function and disease biology through next generation in vitro models. From target discovery to IND submission, Emulate aims to ignite a new era in human health research—one that reduces animal testing, cuts drug development costs, and accelerates the delivery of life-saving treatments. Emulate's Organ-Chip platforms, consumables, and organ models help the world's leading pharmaceutical, biotech, and academic teams generate human-relevant data that advance safer, more effective therapies. Learn more at
Yahoo
3 hours ago
- Yahoo
Missouri continues to lag behind most states in children's health, report finds
(Rebecca Rivas/Missouri Independent). Missouri ranked in the bottom third of all states for children's health, according to a report released Monday — due in part to a high rate of child and teen deaths. The annual Kids Count Data Book from the Annie E. Casey Foundation, which used data from 2023, evaluated all states on four metrics of child well-being: health, economic well-being, education, and family and community. Missouri ranked near the middle of states for overall child well-being, at 27th out of 50, weighed down by poor performance in health and education. Missouri's rankings in the four categories were: 13th in economic well-being, 33rd in education, 35th in health And 25th in family & community. 'Children's health remains an area of concern,' noted a press release Monday from Family and Community Trust, the Missouri-based nonprofit partner to Kids Count. Only nine states had higher rates of child and teen deaths in 2023 than Missouri, one of the factors considered in the health ranking. (Those were: Mississippi, Louisiana, New Mexico, Alabama, Tennessee, Arkansas, Alaska, Oklahoma and Montana.) Missouri generally ranks among the states with the highest rate of firearm deaths for kids. Firearms became the leading cause of kids' deaths in the United States in 2020, surpassing car accidents. While the national average in 2023 was 29 child and teen deaths per 100,000, that number was 37 deaths per 100,000 in Missouri. The national average rose overall in 2023. The report notes that while covid deaths contributed to the increase, the rise was largely due to rising firearm deaths and drug overdoses, particularly among teens ages 15 to 19. Also bringing Missouri's health ranking down: Missouri's rate of low-birth weight babies increased in 2023 from 2019 and is above the national average. Other factors helped Missouri's score. For one, Missouri has seen major improvements in children's insurance coverage since the state implemented Medicaid expansion in 2021. The rate of uninsured kids fell from 7% in 2019 to 5% in 2023, which is now on par with the national average. Nationally, Missouri saw among the sharpest declines in uninsured people overall from 2019 to 2023 with the expansion of Medicaid. Those gains could be threatened by Congress' budget proposal to reduce Medicaid spending in part by imposing more barriers to care. Teen births in the state have gone down, in line with national trends — though the state's average is still above the national one. The rate of overweight or obese kids has also improved in Missouri and is down to 31% of kids in 2023, on par with the national average. The rate of kids in poverty declined to 14% in the state in 2023, below the 16% national average. Missouri's education ranking slipped in recent years. In 2023, 77% of Missouri eighth graders were not proficient at math, according to the report, which is nearly 10 percentage points worse than 2019 and is worse than the national average. The press release from Family and Community Trust said the data show a 'continuing need to invest in education in Missouri.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
Yahoo
4 hours ago
- Yahoo
Canadian doctor after devastating Sudan assignment: 'The worst humanitarian crisis in the world'
Sudan is facing an emergency of staggering proportions, one that has displaced over 12 million people and decimated the nation's healthcare system. But unlike other global crises, this one seems to be happening almost entirely in silence. 'This is not just a war between two parties,' says Sana Bég, executive director of Médecins Sans Frontières (MSF) Canada. 'It's a war on the people of Sudan.' What began as a power struggle between the Sudanese Armed Forces (SAF) and the Rapid Support Forces (RSF) in April 2023 has spiralled into what aid workers now describe as the world's largest displacement crisis. According to the World Health Organization, 70 to 80 per cent of the country's healthcare facilities are either nonfunctional or overwhelmed. In parts of Darfur, even the UN is absent, leaving MSF — also known as Doctors Without Borders — as the only international organization delivering aid on the ground. 'Having to choose between one life-saving activity for another are the kinds of decisions our teams are left to make because of this increasingly isolated environment where we're the only ones being relied on to carry out an entire scope of what should be an ecosystem of aid,' Bég says. This is not just a war between two parties. It's a war on the people of Sudan. For Dr. Reza Eshaghian, a Vancouver-based physician who recently returned from Darfur, the devastation is unlike anything he has seen before. 'What's happening in Sudan is the worst humanitarian crisis in the world, full stop,' he says. 'There are bombings, sexual violence, armed robbery. There's a lack of protection and international humanitarian law.' Eshaghian, who began working with MSF in 2014, was stationed in Nyala, a city in South Darfur. He noted that it's not just the violence itself that is killing people: 'So much of the suffering and death is from preventable illness. We saw women dying from eclampsia and postpartum hemorrhage. People are dying of malaria, malnutrition, diarrhea, dehydration, sepsis. These are things we know how to treat, but there's no infrastructure left to do it.' The hospital Eshaghian helped support saw overwhelming gaps in supplies and staffing. Although MSF brings in its own equipment, the logistics are gruelling, and his team saw supply shipments often delayed. There was also never enough. People are dying of malaria, malnutrition, diarrhea, dehydration, sepsis. These are things we know how to treat, but there's no infrastructure left to do it. Despite the danger, MSF has continued to provide help where it can, but the work has come at immense personal cost, especially for local staff. 'Eighty percent of our workforce globally is locally hired,' Bég notes. 'These are people whose homes are war zones. [They] tell us they have a fear of retaliation or repercussions for any actions that could be interpreted as siding with one warring party or the other. Having to live in fear on a regular basis is far different than what some of our teams that have the ability to get on a plane and leave face.' In other words, simply providing medical care can be seen as a political act. But that doesn't make it any more secure. The safety protocols MSF follows — clearly marked medical uniforms, identified facilities — are no longer a guarantee. 'We used to rely on international humanitarian law to protect aid workers and patients,' she says. 'That's not the reality anymore. Not in Sudan. The sad reality now is that we are no longer able to guarantee safety in the countries that we're operating in, so we're taking it day by day.' Among the most at-risk in Sudan, as is often the case in most war zones, are women and children. In one year alone, MSF supported approximately 8,500 births and performed over 1,600 emergency C-sections across Sudan. 'But the numbers don't tell the full story,' Bég says. 'We're talking about women walking 100 kilometres on foot, often pregnant or with sick children, just to reach care.' Eshaghian recalls one such woman who fled violence in Khartoum and arrived in Nyala with her three-year-old daughter — the last surviving member of her family. 'Her child had a fever. We were able to treat her. But the mother had lost her husband and other children along the way. Everything had been taken from them. And there are endless stories like this one." In many cases, the trauma goes even deeper. MSF staff are seeing widespread evidence of sexual violence being used as a weapon of war. 'Women have been raped while fleeing,' Bég says. 'Survivors end up giving birth to babies born out of rape, then they have to deal with the shame and fear of stigma and retaliation.' The scale of the trauma has pushed MSF to adopt community-based care models that, for example, can look like training trusted women in each village to serve as peer counsellors and connectors to formal care. 'We can't be everywhere,' Bég says. 'But we can empower people to help each other.' Both Bég and Eshaghian say that the world's silence on Sudan is not accidental — it's systemic. 'There are no foreign correspondents in Sudan. No international media,' Bég says. 'We are the eyes to the world, and we see that as a responsibility to speak out about what we're seeing and to call for an urgent scaling of aid.' That lack of visibility means less pressure on governments and organizations like the UN to act. 'UNICEF, UNFPA — their response is small and, in the case of Darfur, they're barely present,' Eshaghian says. 'There's clearly a lack of political and diplomatic pressure from governments who have the power to push for the end of this war.' Bég doesn't mince words. She asks, 'Who gets the privilege of our attention? There are certain conflicts that make it to our feeds, to our social media, to the news. There is an inherent inequity and racism in that itself. Where you live shouldn't determine whether you live, and that is what we're seeing in Sudan — willful ignorance.' Where you live shouldn't determine whether you live. Still, there are reasons to keep going — glimpses of joy, even in the bleakest corners. 'When you visit patients in the hospital, especially children who bounce back from illness and are quite resilient, you see their happiness. [We] took a lot of pride in ... being able to support the community, to see the impact,' Eshaghian says. What MSF is now demanding is clear: A significant increase in humanitarian access, stronger diplomatic pressure on Sudan's warring factions, and more support from countries like Canada. 'Our patients have no choice but to wake up with hope every day,' Bég says. 'The least we can do is show up for them and provide care. Hope is not optional, it's our moral imperative. We have to reject apathy.'